These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38809051)

  • 41. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
    Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
    J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Pyatigorskaya N; Sanz-Morère CB; Gaurav R; Biondetti E; Valabregue R; Santin M; Yahia-Cherif L; Lehéricy S
    Front Neurol; 2020; 11():366. PubMed ID: 32547468
    [No Abstract]   [Full Text] [Related]  

  • 43. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Automated volumetric determination of high R
    Tessema AW; Lee H; Gong Y; Cho H; Adem HM; Lyu I; Lee JH; Cho H
    NMR Biomed; 2022 Nov; 35(11):e4795. PubMed ID: 35775868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
    Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
    J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
    Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O
    Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different iron deposition patterns in hemodialysis patients with and without restless legs syndrome: a quantitative susceptibility mapping study.
    Wang H; Han X; Jin M; Wang LY; Diao ZL; Guo W; Zhang P; Wang Z; Ding HY; Lv H; Zhang ZY; Zhao PF; Li J; Yang ZH; Liu WH; Wang ZC
    Sleep Med; 2020 May; 69():34-40. PubMed ID: 32045852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different iron deposition patterns in Parkinson's disease subtypes: a quantitative susceptibility mapping study.
    Chen J; Cai T; Li Y; Chi J; Rong S; He C; Li X; Zhang P; Wang L; Zhang Y
    Quant Imaging Med Surg; 2020 Nov; 10(11):2168-2176. PubMed ID: 33139996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
    Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantifying iron deposition in the cerebellar subtype of multiple system atrophy and spinocerebellar ataxia type 6 by quantitative susceptibility mapping.
    Sugiyama A; Sato N; Kimura Y; Fujii H; Maikusa N; Shigemoto Y; Suzuki F; Morimoto E; Koide K; Takahashi Y; Matsuda H; Kuwabara S
    J Neurol Sci; 2019 Dec; 407():116525. PubMed ID: 31639532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease.
    Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J
    ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877
    [No Abstract]   [Full Text] [Related]  

  • 54. Combining quantitative susceptibility mapping to radiomics in diagnosing Parkinson's disease and assessing cognitive impairment.
    Kang JJ; Chen Y; Xu GD; Bao SL; Wang J; Ge M; Shen LH; Jia ZZ
    Eur Radiol; 2022 Oct; 32(10):6992-7003. PubMed ID: 35461376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus.
    Hu R; Gao B; Tian S; Liu Y; Jiang Y; Li W; Li Y; Song Q; Wang W; Miao Y
    Front Neurosci; 2023; 17():1061156. PubMed ID: 36793541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative assessment of iron deposition in Parkinson's disease using enhanced T2 star-weighted angiography.
    Ji S; Zhang S; Mao Z; Han H; Yang Q; Zhu W; Zhu S; Xue Z
    Neurol India; 2016; 64(3):428-35. PubMed ID: 27147149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron quantification in basal ganglia: quantitative susceptibility mapping as a potential biomarker for Alzheimer's disease - a systematic review and meta-analysis.
    Ghaderi S; Mohammadi S; Nezhad NJ; Karami S; Sayehmiri F
    Front Neurosci; 2024; 18():1338891. PubMed ID: 38469572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.